Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies

Taking advantage of the immune system to exert an antitumor effect is currently a novel approach in cancer therapy. Adoptive transfer of T cells engineered to express chimeric antigen receptors (CARs) targeting a desired antigen has shown extraordinary antitumor activity, especially in refractory an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Jiali, Zhao, Lei, Zhang, Yuanyuan, Qin, Yun, Guan, Yuqi, Zhang, Tong, Liu, Chaohong, Zhou, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882288/
https://www.ncbi.nlm.nih.gov/pubmed/31824840
http://dx.doi.org/10.3389/fonc.2019.01237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882288/
https://www.ncbi.nlm.nih.gov/pubmed/31824840
http://dx.doi.org/10.3389/fonc.2019.01237

Ejemplares similares